Abstract
Natural halloysite nanotubes (HNTs), with nanotubular structure, are attracting considerable attention in recent years. The hollow tubular structure allows HNTs to play an important role in drug delivery system as drug carriers. However, the wide applications of HNTs in biomedicine have been hampered by the lack of sufficient intracellular researches so far. In this study, we systemically investigated the transport mechanisms of HNTs in A549 living cells. The colocalization and inhibition experiments illustrated FITC-labeled HNTs were readily internalized into cells by both clathrin- and caveolae-dependent endocytosis, and the transport pathway of HNTs is an actin- and microtubule-associated process via Golgi apparatus and lysosome. Meanwhile, the cell cycle assay clarified that HNTs can prompt the intracellular transportation of gemcitabine and enhance the gemcitabine concentration in A549 tumor cells. Such elucidation of intracellular transport pathway of HNTs offers insights into the site-specific delivery and cellular internalization of HNTs, which provide a reasonable guidance for the design of novel drug delivery system.
Similar content being viewed by others
References
Shao W, Paul A, Zhao B, Lee C, Rodes L, Prakash S (2013) Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials 34:10109–10119
Jia N, Lian Q, Shen H, Wang C, Li C, Yang Z (2007) Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 7:2976–2980
Xu ZP, Zeng QH, Lu GQ, Yu AB (2006) Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027–1040
Wang F, Wang YC, Dou S, Xiong MH, Sun TM, Wang J (2011) Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 5:3679–3692
Pissuwan D, Niidome T, Cortie MB (2011) The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 149:65–71
Newman P, Minett A, Ellis-Behnke R et al (2013) Carbon nanotubes: their potential and pitfalls for bone tissue regeneration and engineering. Nanomed Nanotechnol 9:1139–1158
Levis S, Deasy P (2002) Characterisation of halloysite for use as a microtubular drug delivery system. Int J Pharm 243:125–134
Santos AC, Ferreira C, Veiga F, Ribeiro AJ, Panchal A, Lvov Y, Agarwal A (2018) Halloysite clay nanotubes for life sciences applications: from drug encapsulation to bioscaffold. Adv Colloid Interface Sci. https://doi.org/10.1016/j.cis.2018.05.007
Remškar M (2004) Inorganic nanotubes. Adv Mater 16:1497–1504
Joussein E, Petit S, Churchman J, Theng B, Righi D, Delvaux B (2005) Halloysite clay minerals—a review. Clay Miner 40:383–426
Kryuchkova M, Danilushkina A, Lvov YM et al (2016) Evaluation of toxicity of nanoclays and graphene oxide in vivo: a paramecium caudatum study. Environ Sci Nano 3:442–452
Lvov YM, DeVilliers MM, Fakhrullin RF (2016) The application of halloysite tubule nanoclay in drug delivery. Expert Opin Drug Deliv 13:977–986
Vergaro V, Lvov YM, Leporatti S (2012) Halloysite clay nanotubes for resveratrol delivery to cancer cells. Macromol Biosci 12:1265–1271
Shi YF, Tian Z, Zhang Y, Shen HB et al (2011) Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides. Nanoscale Res Lett 6:1–7
Vergaro V, Abdullayev E, Lvov YM, Zeitoun A, Cingolani R et al (2010) Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromol 11:820–826
Fix D, Andreeva DV, Lvov YM, Shchukin DG, Möhwald H (2009) Application of inhibitor-loaded halloysite nanot ubes in active anti-corrosive coatings. Adv Funct Mater 19:1720–1727
Fakhrullina GI, Akhatova FS, Lvov YM et al (2015) Toxicity of halloysite clay nanotubes in vivo: a caenorhabditis elegans study. Environ Sci Nano 2:54–59
Wu H, Shi Y, Huang C, Zhang Y, Wu J et al (2014) Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing. J Biomater Appl 28:1180–1189
Dzamukova MR, Naumenko EA, Lvov YM et al (2015) Enzyme-activated intracellular drug delivery with tubule clay nanoformulation. Sci Rep UK 5:10560
Massaro M, Lazzara G, Milioto S, Noto R, Riela S (2017) Covalently modified halloysite clay nanotubes: synthesis, properties, biological and medical applications. J Mater Chem B 5(16):2867–2882
Verma NK, Moore E, Blau W, Volkov Y et al (2012) Cytotoxicity evaluation of nanoclays in human epithelial cell line A549 using high content screening and real-time impedance analysis. J Nanopart Res 14:1–11
Price R, Gaber BP, Lvov YM (2011) In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. J Microencapsul 18:713–722
Abdullayev E, Price R, Shchukin D, Lvov YM (2009) Halloysite tubes as nanocontainers for anticorrosion coating with benzotriazole. ACS Appl Mater Interfaces 1:1437–1443
Liu P, Zhao M (2009) Silver nanoparticle supported on halloysite nanotubes catalyzed reduction of 4-nitrophenol (4-NP). Appl Surf Sci 255:3989–3993
Veerabadran NG, Mongayt D, Torchilin V, Price R, Lvov YM (2009) Organized shells on clay nanotubes for controlled release of macromolecules. Macromol Rapid Commun 30:99–103
Serag MF, Kaji N, Venturelli E, Okamoto Y, Terasaka K et al (2011) Functional platform for controlled subcellular distribution of carbon nanotubes. ACS Nano 5:9264–9270
Khandare JJ, Jalota-Badhwar A, Satavalekar SD, Bhansali SG et al (2012) PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging. Nanoscale 4:837–844
Burris HA, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413
Martoni A, Marino A, Sperandi F et al (2005) Multicentre randomized phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer 41:81–92
Yah WO, Takahara A, Lvov YM (2012) Selective modification of halloysite lumen with octadecylphosphonic acid: new inorganic tubular micelle. J Am Chem Soc 134:1853–1859
Yuan P, Southon PD, Liu Z, Green ME, Hook JM, Antill SJ, Kepert CJ (2008) Functionalization of halloysite clay nanotubes by grafting with γ-aminopropyltriethoxysilane. J Phys Chem C 112:15742–15751
Li J, Wang R, Schweickert PG et al (2016) Plk1 Inhibition Enhances the Efficacy of Gemcitabine in Human Pancreatic Cancer. Cell Cycle 15:711–719
Zeng YC, Wu R, Xiao YP et al (2015) Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitro. Contemp Oncol 19:236–240
Mailander V, Landfester K (2009) Interaction of nanoparticles with cells. Biomacromol 10:2379–2400
Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422:37–44
Kam NWS, Liu Z, Dai H (2006) Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed 118:591–595
Hillaireau H, Couvreur P (2009) Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66:2873–2896
Liu SL, Zhang ZL, Tian ZQ et al (2011) Effectively and efficiently dissecting the infection of influenza virus by quantum-dot-based single-particle tracking. ACS Nano 6:141–150
Fang J, Nakamura H, Maeda H (2011) The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–151
Jin SE, Jin HE, Hong SS (2014) Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics. Biomed Res Int 2014:814208
Maeda H, Bharate GY, Daruwalla J (2009) Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71:409–419
Watari F, Takashi N, Yokoyama A et al (2009) Material nanosizing effect on living organisms: non-specific, biointeractive, physical size effects. J R Soc Interface 6:S371–S388
Kryuchkova M, Danilushkina A, Lvov Y, Fakhrullin R (2016) Evaluation of toxicity of nanoclays and graphene oxide in vivo: a Paramecium caudatum study. Environ Sci Nano 3(2):442–452
Acknowledgements
This work was supported by China Scholarship Council (No.201208420587). The authors would also like to thank Prof. Daiwen Pang at Wuhan University for technical help with confocal microscopy and Dr. Matthew Glen and Dr. Lynne Waddington at CSIRO in Australia for technical assistance on SEM and TEM.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liu, H., Wang, ZG., Liu, SL. et al. Intracellular pathway of halloysite nanotubes: potential application for antitumor drug delivery. J Mater Sci 54, 693–704 (2019). https://doi.org/10.1007/s10853-018-2775-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10853-018-2775-5